Sorangicin A Is Active against <i>Chlamydia</i> in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment

Current treatment of <i>Chlamydia trachomatis</i> using doxycycline and azithromycin introduces detrimental side effects on the host’s microbiota. As a potential alternative treatment, the myxobacterial natural product sorangicin A (SorA) blocks the bacterial RNA polymerase. In this study we analyze...

Полное описание

Библиографические подробности

Главные авторы:	Simon Graspeuntner, Katharina Koethke, Celeste Scholz, Lea Semmler, Mariia Lupatsii, Laura Kirchhoff, Jennifer Herrmann, Katharina Rox, Kathrin Wittstein, Nadja Käding, Lars C. Hanker, Marc Stadler, Mark Brönstrup, Rolf Müller, Kensuke Shima, Jan Rupp
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2023-04-01
Серии:	Antibiotics
Предметы:	sorangicin A antibiotics <i>Chlamydia trachomatis</i> <i>Chlamydia muridarum</i> mouse novel therapeutics
Online-ссылка:	https://www.mdpi.com/2079-6382/12/5/795
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!